Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo
Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo
NCT ID: NCT04872257 Phase: NA Status: COMPLETED Enrollment: 26 Completion: 2022-11-01
Conditions
Vitiligo, Vitiligo, Generalized, Autoimmune, Autoimmune Diseases, Autoimmune Disease Skin
Interventions
Oral Vitamin D, NB-UVB Phototherapy, Placebo
Summary
A randomized clinical trial that treats vitiligo patients with oral vitamin D and Narrow-Band Ultraviolet B (NB-UVB) phototherapy (intervention group); or placebo and NB-UVB phototherapy (control group). We will evaluate if the group supplemented with vitamin D achieves a higher repigmentation rate than the control group, proving the relevance of vitamin D as an immunomodulator in the pathophysiology of vitiligo. These findings may support the use of vitamin D as an economic, safe, and adjuvant treatment for vitiligo.
Primary Outcome
VASI score - Vitiligo Area and Severity Index (VASI)